In patients with breast cancer, for instance, increases in SF are strongly correlated with FTL rather than with FTH1, whereas these increases may be due to FTH1 overexpression in patients with acute myeloid leukemia (AML). The gene discussed is FTH1; the disease is breast carcinoma.